Nakashima A - Search Results

1

Bone mineral density may be related to atherosclerosis in hemodialysis patients.

Nakashima A, Yorioka N, Tanji C, Asakimori Y, Ago R, Usui K, Shigemoto K, Harada S. Nakashima A, et al. Osteoporos Int. 2003 Jun;14(5):369-73. doi: 10.1007/s00198-002-1361-4. Epub 2003 May 24. Osteoporos Int. 2003. PMID: 12768278

2

Radial bone mineral density in hemodialysis patients with adynamic bone disease.

Nakashima A, Yorioka N, Doi S, Ueda C, Usui K, Shigemoto K, Harada S. Nakashima A, et al. Int J Artif Organs. 2003 Mar;26(3):200-4. doi: 10.1177/039139880302600304. Int J Artif Organs. 2003. PMID: 12703885

3

Different risk factors for the maximum and the mean carotid intima-media thickness in hemodialysis patients.

Nakashima A, Yorioka N, Asakimori Y, Ito T, Masaki T, Shigemoto K, Harada S. Nakashima A, et al. Intern Med. 2003 Nov;42(11):1095-9. doi: 10.2169/internalmedicine.42.1095. Intern Med. 2003. PMID: 14686748 Free article.

4

Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.

Nakashima A, Yorioka N, Doi S, Masaki T, Ito T, Harada S. Nakashima A, et al. Bone. 2004 Mar;34(3):579-83. doi: 10.1016/j.bone.2003.11.016. Bone. 2004. PMID: 15003806

5

HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus.

Nakashima A, Nakashima R, Ito T, Masaki T, Yorioka N. Nakashima A, et al. Among authors: nakashima r. Diabet Med. 2004 Sep;21(9):1020-4. doi: 10.1111/j.1464-5491.2004.01292.x. Diabet Med. 2004. PMID: 15317608

6

Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients.

Nakashima A, Yorioka N, Mizutani T, Yamagata Z, Ueno T, Takasugi N. Nakashima A, et al. Nephron Clin Pract. 2005;99(3):c78-85. doi: 10.1159/000083418. Epub 2005 Jan 19. Nephron Clin Pract. 2005. PMID: 15665550

7

Osteoprotegerin and bone mineral density in hemodialysis patients.

Nakashima A, Yorioka N, Doi S, Takasugi N, Shigemoto K, Kohno N. Nakashima A, et al. Osteoporos Int. 2006;17(6):841-6. doi: 10.1007/s00198-005-0047-0. Epub 2006 Apr 7. Osteoporos Int. 2006. PMID: 16604298

8

Performance of polysulfone membrane dialyzers and dialysate flow pattern.

Nakashima A, Ogata S, Doi S, Yamahira M, Naraki S, Takasugi N, Ohmoto T, Ito T, Masaki T, Yorioka N. Nakashima A, et al. Clin Exp Nephrol. 2006 Sep;10(3):210-5. doi: 10.1007/s10157-006-0431-x. Clin Exp Nephrol. 2006. PMID: 17009079

9

Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.

Doi S, Masaki T, Arakawa T, Takahashi S, Kawai T, Nakashima A, Naito T, Kohno N, Yorioka N. Doi S, et al. Among authors: nakashima a. Transplantation. 2007 Jul 27;84(2):207-13. doi: 10.1097/01.tp.0000269614.21367.3f. Transplantation. 2007. PMID: 17667812

10

DEC1 modulates the circadian phase of clock gene expression.

Nakashima A, Kawamoto T, Honda KK, Ueshima T, Noshiro M, Iwata T, Fujimoto K, Kubo H, Honma S, Yorioka N, Kohno N, Kato Y. Nakashima A, et al. Mol Cell Biol. 2008 Jun;28(12):4080-92. doi: 10.1128/MCB.02168-07. Epub 2008 Apr 14. Mol Cell Biol. 2008. PMID: 18411297 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

999 results

Search Page

Filters